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Is Functional Status Better in 
U.S. Patients With Cardiac 
Disease Than in Their 
Canadian Counterparts?* 
RICHARD C. SCHLANT, MD, FACC 
Atlanta, Georgia 
In this issue of the Journal, Pilote et al. (1) report data from 
the Study of Economics and Quality of Life (SEQOL), an 
ancillary study of the Bypass A_ngioplasty Revascularization 
Investigation (BARI) (2), which is a multicenter, randomized 
trial of coronary angioplasty and coronary artery bypass ur- 
gery as the initial revascularization strategy in patients with 
multivessel coronary disease. Data to assess quality of life 
before the events leading to enrollment in BARI were ob- 
tained from patients at seven sites in the United States and at 
one site in Canada (the Montreal Heart Institute). Many 
patients in BARI had symptoms of heart disease before the 
development of symptoms of myocardial infarction or unstable 
angina for which they were enrolled in BARI. Such patients in 
the United States had a higher functional status than similar 
patients in Montreal. Pilote et al. suggest that this difference 
may be due to different patterns of medical management of 
heart disease in the two countries. 
Two aspects of the study deserve special consideration: 
1) Are the differences between the quality of life data from 
patients in the seven sites in the United States and from 
patients in Montreal clinically meaningful? 2) If the differ- 
ences are real, what are the likely causes of the differences? 
In the study by Pilote et al., the patients ranked their 
perceptions of their own general health on a five-point scale, 
whereas their functional capacity was assessed by the Duke 
Activity Status Index (3), a brief self-administered question- 
naire that consists of 12 simple questions about specific daily 
activities in English. Because many patients in Montreal arc 
French-speaking, it was necessary to translate the question- 
naire for some patients. Presumably, the translations wcrc 
performed by the research nurses at the Montreal Heart 
Institute. 
The authors note that of the total of 934 patients in the 
United States, 30% ranked their overall health as excellent or 
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very good, whereas only 20% of the total of 278 patients in 
Montreal ranked their global health in these categories. If, 
however, one includes the next category (good), the combined 
percentages of patients who ranked their health in the top 
three categories in the two countries are much closer: 71% in 
the United States and 68% in Canada. 
The Duke Activity Status Index of patients who had 
symptoms of heart disease before the development of the 
symptoms of the index episode of myocardial infarction or 
unstable angina that led to enrollment in BARI was higher 
in the 653 patients in the United States (mean 18.3, median 
13) than in the 207 patients in Montreal (mean 15.2, median 
10). In addition, 27% of such patients in the United States 
rated their overall health as "excellent" or "very good" 
compared with only 16% in Montreal. However, if one 
includes the next category (good), then 67% of patients in 
the United States and 65% of patients in Montreal ranked 
their overall health as excellent, very good or good. In the 
smaller subgroup of patients who did not have prior symp- 
toms of heart disease before myocardial infarction or onset 
of unstable angina, 35% of 279 U.S. patients classified their 
overall health as either excellent or very good compared 
with 30% of 71 Canadian patients who classified their health 
in these two categories. In both countries, 77% of this group 
of patients ranked their overall health as excellent, very 
good or good before their index episode of acute ischemic 
heart disease. The functional status of patients in this group 
in Montreal was slightly higher (mean Duke Activity Status 
Index 31.9, median 27) than in the United States (mean 
index 26.9, median 26). 
Pilote et al. conclude that the lower functional status in the 
symptomatic Canadian patients before their index episode may 
be due to differences in the medical management of heart 
disease in the two countries (4-11) rather than to differences 
in climate, culture, race or language. If symptomatic patients in 
the United States have greater access to cardiologists, and if 
cardiologists in the United States are more likely to recom- 
mend coronary angiography and eventually coronary revascu- 
larization for a greater number of patients with both severe 
and only moderately severe symptoms, the remaining pool of 
patients with symptomatic coronary artery disease in the 
United States might be expected to have, on average, less 
severe symptomatic disease than a similar group of patients in 
Canada (12). 
Before accepting the conclusions that symptomatic Ca- 
nadian patients have a lower functional status than their 
counterparts in the United States and that this difference is
due to differences in medical practice in the two countries, 
one would like to see the findings of this study verified in 
larger studies utilizing many more subjects in several differ- 
ent Canadian centers. In addition, it will be necessary to 
account for several other potential forms of bias. For 
example, one would need to know whether or not the 
patient's assessment of quality of life, including functional 
capacity, might in any way be influenced by different policies 
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in the two countries regarding retirement or workmans' 
compensation or reimbursement payments (secondary 
gain). 
At present, the waiting times for elective and urgent 
coronary angiography and elective and urgent coronary 
bypass urgery are significantly onger in Canada than in the 
United States (5,6,11). In addition, there is evidence that 
physicians in the United States use cardiac procedures more 
often than do physicians in Canada (4,5,7-10), although this 
greater use of invasive procedures and some cardiac medi- 
cations in the United States has not yet been shown to be 
associated with a significant difference in long-term survival 
(7,9). In the Global Utilization of Streptokinase and Tissue 
Plasminogen Activator for Occluded Arteries (GUSTO) 
study, however, the functional status of patients 1year after 
the reference myocardial infarction was better in patients 
treated in the United States than in those treated in Canada, 
where the patients had a less aggressive pattern of care (8). 
Similarly, in the Survival and Ventricular Enlargement 
(SAVE) study, patients treated in the United States had a 
lower frequency of activity-limiting angina than those 
treated in Canada, although there was no apparent differ- 
ence in mortality rate (7). 
Long-term follow-up of patients in these and other 
studies is important o determine whether or not the 
considerably greater expenditure ofmoney for management 
of patients with cardiovascular disease in the United States 
will be reflected in improved mortality in addition to better 
quality of life. 
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